CBNK
Capital Bancorp, Inc.
CBNK offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has a slight edge over CBNK overall, supported by stronger modeled upside and stronger valuation.
CBNK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
CBNK's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CBNK.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CBNK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.8x | $25.86 | -38% |
| Fair | 9.1x | $30.16 | -28% |
| Forward | 11x | $41.97 | — |
| Expensive | 12x | $38.55 | -8.1% |
| Current | 13x | $41.97 | — |
Historical ranges are pointers, not guarantees.
CBNK's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over CBNK in the historical PE scenario, which offers more potential upside but is not a forecast.
CBNK Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
CBNK has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CBNK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.81 | +15% |
| Q3 2026 | $3.32 | +13% |
| Q2 2026 | $3.41 | +28% |
| Q1 2026 | $3.32 | +34% |
| Q4 2025 | $3.41 | +61% |
| Q3 2025 | $2.93 | +26% |
| Q2 2025 | $2.66 | +10% |
| Q1 2025 | $2.47 | +5.6% |
| Q4 2024 | $2.12 | -17% |
CBNK earned $3.32 per share over the past year, up 13% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CBNK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $68.1M | +8% |
| Q2 2026 | $65.3M | +7.5% |
| Q1 2026 | $62.8M | +7.1% |
| Q4 2025 | $62.7M | +12% |
| Q3 2025 | $63.1M | +40% |
| Q2 2025 | $60.8M | +38% |
| Q1 2025 | $58.6M | +43% |
| Q4 2024 | $56.2M | +38% |
CBNK has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | +27 points |
| Q2 2026 | 28% | +30 points |
| Q1 2026 | 25% | +27 points |
| Q4 2025 | 31% | +33 points |
| Q3 2025 | -1.5% | +0.8 points |
| Q2 2025 | -1.5% | +0.2 points |
| Q1 2025 | -1.5% | +0.7 points |
| Q4 2024 | -1.8% | -29 points |
CBNK's operating margin was 26% last quarter, up 27 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CBNK on profitability, with a higher operating margin.
CBNK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $35.4M | +7.7% |
| Q2 2026 | -$5M | -$819K |
| Q1 2026 | $21.8M | -3.6% |
| Q4 2025 | $18.5M | -29% |
| Q3 2025 | $32.9M | +$33.4M |
| Q2 2025 | -$4.2M | -133% |
| Q1 2025 | $22.6M | +$26M |
| Q4 2024 | $25.9M | +318% |
CBNK has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CBNK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +109K shares |
| 1 year | -2.1% | -362K shares |
| 3 years | +18% | +2.5M shares |
| 5 years | +16% | +2.3M shares |
| Available history | +18% | +2.5M shares |
CBNK has 16M diluted shares, down 2.1% from a year ago, with $12M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $36,000 |
| Q1 2026 | $3.6M |
| Q4 2025 | $8.6M |
| Q3 2025 | $312,000 |
| Q2 2025 | $2.9M |
| Q1 2025 | $618,000 |
| Q4 2024 | — |
CBNK spent $12M buying back its own shares over the past year, about three times what it spent the year before.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CBNK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CBNK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.5x | Net Cash |
| Q4 2025 | -1.5x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | -0.0x | Net Cash |
| Q4 2023 | 0.3x | Very low |
CBNK has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CBNK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.7 | Neutral |
| Stochastic | 78.3 | Neutral |
CBNK's weekly RSI is 70 (neutral) and its Stochastic is 78 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CBNK PE vs Financial Services Sector
| Metric | CBNK | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 2.9% below |
| PE % | 90 | 63 | 27 pts above |
CBNK has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
CBNK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.3 | 4.3% above |
| 20 week MA | $38.0 | 11% above |
| 50 week MA | $33.6 | 25% above |
| 100 week MA | $32.1 | 31% above |
| 200 week MA | $26.7 | 57% above |
CBNK has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
CBNK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.7 | $13.6 | -7.2% |
| 2021 | $13.6 | $26.1 | +91% |
| 2022 | $26.1 | $23.7 | -9.3% |
| 2023 | $23.7 | $24.2 | +2.3% |
| 2024 | $24.2 | $28.6 | +18% |
| 2025 | $28.6 | $28.5 | -0.4% |
| 2026 YTD | $28.5 | $42.0 | +47% |
CBNK has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.